πŸ‡ΊπŸ‡Έ FDA
Patent

US 6951885

Pharmaceutical composition

expired A61KA61K31/18A61K31/215

Quick answer

US patent 6951885 (Pharmaceutical composition) held by Takeda Pharmaceutical Company Limited expires Mon Sep 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Oct 04 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/18, A61K31/215, A61K31/27, A61K31/41